Hypokalemia induces renal injury and alterations in vasoactive mediators that favor salt sensitivity.
暂无分享,去创建一个
Y. G. Kim | M Mazzali | M I Phillips | J. Hughes | S. Suga | C. Vio | P. Ray | R. Johnson | J. Raleigh | K. Gordon | J A Raleigh | M. Phillips | P E Ray | S I Suga | C P Vio | Y G Kim | K L Gordon | J Hughes | R J Johnson | M. Mazzali | Yoon-Goo Kim | R. Johnson | Jeremy Hughes | James A. Raleigh | Shinichi Suga | Patricio E. Ray | Carlos P. Vio | Katherine L. Gordon | Richard J. Johnson | Shin-ichi Suga
[1] S. Kalra,et al. Dynamic changes in hypothalamic angiotensin II levels and release in association with progesterone-induced luteinizing hormone surge. , 1993, Endocrinology.
[2] R. Kunau,et al. Effect of potassium deficiency on papillary plasma flow in the rat. , 1979, The American journal of physiology.
[3] L. Wei,et al. Expression and characterization of recombinant human angiotensin I-converting enzyme. Evidence for a C-terminal transmembrane anchor and for a proteolytic processing of the secreted recombinant and plasma enzymes. , 1991, The Journal of biological chemistry.
[4] J. C. Romero,et al. Mechanisms Underlying Pressure‐Related Natriuresis: The Role of the Renin‐Angiotensin and Prostaglandin Systems State of the Art Lecture , 1988, Hypertension.
[5] T. Kotchen,et al. Effect of potassium depletion on renin release. , 1982, Kidney international.
[6] S. Kapoor,et al. Potassium depletion exacerbates essential hypertension. , 1991, Annals of internal medicine.
[7] T. Slowinski,et al. Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension. , 1997, The Journal of clinical investigation.
[8] F. Epstein,et al. On the mechanism of the effects of potassium restriction on blood pressure and renal sodium retention. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[9] S. Rosen,et al. HYPOKALEMIC NEPHROPATHY IN RAT AND MAN: A LIGHT AND ELECTRON MICROSCOPIC STUDY. , 1964, Laboratory investigation; a journal of technical methods and pathology.
[10] A. Bohle,et al. Morphologic aspects of low-potassium and low-sodium nephropathy. , 1983, Clinical nephrology.
[11] L. Chao,et al. Potassium supplement upregulates the expression of renal kallikrein and bradykinin B2 receptor in SHR. , 1999, The American journal of physiology.
[12] J. Mehta,et al. Increased superoxide anion generation and altered vasoreactivity in rabbits on low-potassium diet. , 1998, American journal of physiology. Heart and circulatory physiology.
[13] R. Largo,et al. Mycophenolate mofetil prevents salt-sensitive hypertension resulting from angiotensin II exposure. , 2001, Kidney international.
[14] C. Vio,et al. Long-term nitric oxide synthase inhibition in rat pregnancy reduces renal kallikrein. , 1999, Hypertension.
[15] S. Suga,et al. Renal injury and salt-sensitive hypertension after exposure to catecholamines. , 1999, Hypertension.
[16] C. Figueroa,et al. Evidence for a stimulatory effect of high potassium diet on renal kallikrein. , 1987, Kidney international.
[17] G. Arteel,et al. Cyclosporin A increases hypoxia and free radical production in rat kidneys: prevention by dietary glycine. , 1998, The American journal of physiology.
[18] G. G. Krishna. Hypokalemic states: current clinical issues. , 1990, Seminars in nephrology.
[19] P. Klotman,et al. Renal vascular induction of TGF-β2 and renin by potassium depletion , 1993 .
[20] N. Beck,et al. Thromboxane B2 and prostaglandin E2 in the K+-depleted rat kidney. , 1981, The American journal of physiology.
[21] S. Linas,et al. Mechanism of the decreased renal blood flow in the potassium-depleted conscious rat. , 1981, Kidney International.
[22] R. Buñag,et al. Tail‐Cuff Blood Pressure Measurement without External Preheating in Awake Rats , 1982, Hypertension.
[23] M. Dunn,et al. Urinary excretion of prostaglandin E2 and prostaglandin F2alpha in potassium-deficient rats. , 1978, Prostaglandins.
[24] S. Schwartz,et al. Salt-sensitive hypertension develops after short-term exposure to Angiotensin II. , 1999, Hypertension.
[25] S. Schwartz,et al. Renal and Vascular Injury Induced by Exogenous Angiotensin II Is AT1 Receptor-Dependent , 2001, Nephron.
[26] E. Krieger,et al. State-of-the-Art lecture: influence of exercise training on neurogenic control of blood pressure in spontaneously hypertensive rats. , 1999, Hypertension.
[27] R. Prior,et al. Sample pretreatment with nitrate reductase and glucose-6-phosphate dehydrogenase quantitatively reduces nitrate while avoiding interference by NADP+ when the Griess reaction is used to assay for nitrite. , 1995, Analytical biochemistry.
[28] J. Mehta,et al. Critical role of AT1 receptor expression after ischemia/reperfusion in isolated rat hearts: beneficial effect of antisense oligodeoxynucleotides directed at AT1 receptor mRNA. , 1998, Circulation research.
[29] G. Capasso,et al. Potassium and sodium transport along the loop of Henle: effects of altered dietary potassium intake. , 1994, Kidney international.
[30] C. Alpers,et al. Osteopontin expression in angiotensin II-induced tubulointerstitial nephritis. , 1994, Kidney international.
[31] J. C. Vuletin,et al. A Light and Electron Microscopic Study , 1976 .
[32] M. Brezis,et al. Chronic cyclosporine-induced nephropathy in the rat. A medullary ray and inner stripe injury. , 1990, Transplantation.
[33] R. Johnson,et al. Hypothesis: the role of acquired tubulointerstitial disease in the pathogenesis of salt-dependent hypertension. , 1997, Kidney international.
[34] S. Kapoor,et al. Increased blood pressure during potassium depletion in normotensive men. , 1989, The New England journal of medicine.
[35] A. Maxwell,et al. The effect of hypobaric hypoxia on misonidazole binding in normal and tumour-bearing mice. , 1989, British Journal of Cancer.
[36] G. Arteel,et al. Reductive metabolism of the hypoxia marker pimonidazole is regulated by oxygen tension independent of the pyridine nucleotide redox state. , 1998, European journal of biochemistry.
[37] M. Mitchell,et al. Hypokalaemia stimulates prostacyclin synthesis in the rat. , 1983, Clinical science.
[38] F. Epstein. Oxygen and renal metabolism. , 1997, Kidney international.
[39] H. Langford. Potassium in hypertension. , 1983, Postgraduate medicine.
[40] R. Stahl,et al. Inhibition of rabbit renal prostaglandin E2 biosynthesis by chronic potassium deficiency. , 1981, The Journal of laboratory and clinical medicine.
[41] J. Ménard,et al. Renal proliferative and phenotypic changes in rats with two-kidney, one-clip Goldblatt hypertension. , 1994, American journal of hypertension.
[42] Y. G. Kim,et al. Post-cyclosporine-mediated hypertension and nephropathy: amelioration by vascular endothelial growth factor. , 2001, American journal of physiology. Renal physiology.
[43] O. Carretero,et al. Immunocytochemical localization of renin and kallikrein in the rat renal cortex. , 1986, Kidney international.
[44] V. Velarde,et al. Localization of components of the kallikrein-kinin system in the kidney: relation to renal function. State of the art lecture. , 1992, Hypertension.
[45] G. Arteel,et al. Evidence that hypoxia markers detect oxygen gradients in liver: pimonidazole and retrograde perfusion of rat liver. , 1995, British Journal of Cancer.
[46] S. E. Thomas,et al. Tubulointerstitial disease in aging: evidence for underlying peritubular capillary damage, a potential role for renal ischemia. , 1998, Journal of the American Society of Nephrology : JASN.
[47] N. Glorioso,et al. Kallikrein-kinin system and blood pressure sensitivity to salt. , 1997, Hypertension.
[48] C. Baylis,et al. Acute changes in urinary excretion of nitrite + nitrate do not necessarily predict renal vascular NO production. , 1995, Kidney international.
[49] C. Baylis,et al. Chronic nitric oxide inhibition model six years on. , 1998, Hypertension.
[50] T. Hostetter,et al. Hypokalemic nephropathy in the rat. Role of ammonia in chronic tubular injury. , 1987, The Journal of clinical investigation.
[51] O. Carretero,et al. Effect of high salt intake in mutant mice lacking bradykinin-B2 receptors. , 1997, Hypertension.
[52] R. Largo,et al. Mycophenolate mofetil prevents salt-sensitive hypertension resulting from nitric oxide synthesis inhibition. , 2001, American journal of physiology. Renal physiology.